ANDA 208765, held by Dr Reddys Labs SA. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 208765 (Doxycycline Hyclate), held by Dr Reddys Labs SA, was first approved by FDA on Jun 14, 2017, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 14, 2017 | Original application | Approved |
| Doxycycline HyclateEQ 75MG BASE · tablet;oral | Doxycycline Hyclate | Rx |
| Doxycycline HyclateEQ 150MG BASE · tablet;oral | Doxycycline Hyclate | Rx |
| Jun 30, 2023 | Supplement 1Labeling · Standard review | Approved | None posted |
| Jun 30, 2023 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jun 30, 2023 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jun 14, 2017 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters